Patent Grant
10486001
The present invention generally relates to face masks used in the medical field, and other industrial applications.
Face masks have been used throughout the medical industry not only for the medical provider but also for the patient. Personal protective equipment (PPE) refers to face masks and other protective clothing, helmets, gloves, face shields, goggles, and/or respirators or other equipment designed to protect the wearer from injury or the spread of infection or illness. PPE is commonly used in health care settings such as hospitals, doctor's offices and clinical labs. When used properly, PPE acts as a barrier between infectious materials such as viral and bacterial contaminants and the skin, mouth, nose, or eyes (mucous membranes). The barrier has the potential to block transmission of contaminants from blood, body fluids, or respiratory secretions. PPE may also protect patients who are at high risk for contracting infections through a surgical procedure or who have a medical condition, such as, an immunodeficiency from being exposed to substances or to potentially infectious materials brought in by visitors and healthcare workers. When used properly with other infection control practices such as hand-washing, using alcohol-based hand sanitizers, and covering coughs and sneezes, PPE minimizes the spread of infection from one person to another. Effective use of PPE includes properly removing and disposing of contaminated PPE to prevent exposing both the wearer and other people to infection.
If worn properly, a face mask is a barrier that helps block large-particle droplets, splashes, sprays or splatters that may contain germs (viruses and bacteria). This barrier either keeps that fluid from escaping into the environment or from entering into the wearer's mouth and nose.
By applying a scent agent to the face mask, the medical provider may be able to provide longer bedside care. Also, and perhaps more importantly, a cancer patient wearing a scented face mask may feel more comfortable, decreasing the quantity of medications the patient consumes (less anti-nausea medications for example). For instance, in one case study, a patient emerging from a successfully completed chemotherapy regimen attempted to purchase a juice drink at a local store. The smells in that juice store, however, triggered nausea, loss of appetite and other symptoms. (This distorted association is not uncommon for cancer patients. Often times patients associate certain things to taste and smells, causing anxiety, nutritional complications and difficult quality of life indications.) The sensitivity of smell started affecting this patient in the hospital as well. Each time the patient would enter the hospital for routine labs and chemotherapy, the nausea would begin and cause the patient to not want to enter the building. Home care was also affected because the smell of chemotherapy was all over the bed, sheets, room and parts of the house.
A scented face mask can mitigate these nausea-triggering smells. However, past face mask designs simply applied a scent to the mask material, and that scent would vaporize off the mask very quickly. Other scented masks were placed in a sealed bag to prevent the vaporization and prolong the shelf life of the mask. This too, had its drawbacks in that the user could not simply place the mask on their face; rather, they would need to remove the sealed packaging and then wear the mask. This is time consuming, potentially less hygienic, and creates more waste.
What is needed, therefore, is a scented face mask, with a prolonged shelf life that will begin to release its scent once the user places the mask on her face.
A scented mask is disclosed that includes: a filter region with one or more pleats that includes a mask material and a pleat fold as well as one or more scented patches. Each scented patch includes a patch lid attached to the mask material before the pleat fold, a patch-impermeable layer attached to the mask material after the pleat fold, and a layer impregnated with a scent agent attached to the patch-impermeable layer. The mask is constructed to transition from a sealed configuration to an unsealed configuration when a user places the mask over his or her nose and mouth: the sealed configuration, where the mask material before and after the pleat fold are folded on each other and the patch lid covers and seals the impregnated layer, inhibiting the vaporization of the scent agent, and the unsealed configuration, where the pleat fold is opened and the patch lid is separated from the impregnated layer, allowing for the vaporization of the scent agent.
The mask may include an elastic strap to maintain the position of the mask on the user. A memory metal strip may be included to shape an edge of the mask around the user's nose.
The scented patch may include a diffusion layer that covers at least a portion of the impregnated layer when in the unsealed configuration, so as to reduce the rate of vaporization of the scent agent. The scented patch may have an aesthetic shape, like that of a butterfly silhouette. The scented patch may include an indicator that is hidden when the mask is in the sealed configuration and exposed when the mask is in the unsealed configuration. The indicator may be a color and/or a pattern.
The impregnated layer may be constructed from plastic films with pores or micro-holes, paper, sponge-like films, films with encapsulated scent agents, treated plastic films, and combinations thereof. The impregnated layer may be exposed on the face-side of the mask when in the unsealed configuration. The patch lid and the patch-impermeable layer may be attached to the mask material by an adhesive, mechanical fastener or ultrasonic welding. The patch lid and patch-impermeable layer may be connected to each other by a patch hinge, and the patch hinge may be adjacent to the pleat fold.
The scent agent may include a binding agent or an antimicrobial that is selected from a group consisting of: carboxymethyl cellulose, pullulan, hydroxypropyl methyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, polyvinyl pyrrolidone, polyvinyl alcohol, sodium alginate, polyethylene glycol, Xanthan gum, tragacanth gum, guar gum, acacia gum, arabic gum, polyacrylic acid, methyl methacrylate copolymer, carboxyvinyl polymer, amylose, high amylose starch, hydroxypropylated high amylose starch, dextrine, pectin, chitin, chitosan, levan, elsinan, collagen, gelatin, Zein, gluten, soy protein isolate, whey protein isolate, casein, and any combination thereof.
Additional aspects, alternatives and variations as would be apparent to persons of skill in the art are also disclosed herein and are specifically contemplated as included as part of the invention. The invention is set forth only in the claims as allowed by the patent office in this or related applications, and the following summary descriptions of certain examples are not in any way to limit, define or otherwise establish the scope of legal protection.
The invention can be better understood with reference to the following figures. The components within the figures are not necessarily to scale, emphasis instead being placed on clearly illustrating example aspects of the invention. In the figures, like reference numerals designate corresponding parts throughout the different views and/or embodiments. Furthermore, various features of different disclosed embodiments can be combined to form additional embodiments, which are part of this disclosure. It will be understood that certain components and details may not appear in the figures to assist in more clearly describing the invention.
Reference is made herein to some specific examples of the present invention, including any best modes contemplated by the inventor for carrying out the invention. Examples of these specific embodiments are illustrated in the accompanying figures. While the invention is described in conjunction with these specific embodiments, it will be understood that it is not intended to limit the invention to the described or illustrated embodiments. To the contrary, it is intended to cover alternatives, modifications, and equivalents as may be included within the spirit and scope of the invention as defined by the appended claims.
In the following description, numerous specific details are set forth in order to provide a thorough understanding of the present invention. Particular example embodiments of the present invention may be implemented without some or all of these specific details. In other instances, process operations well known to persons of skill in the art have not been described in detail in order not to obscure unnecessarily the present invention. Various techniques and mechanisms of the present invention will sometimes be described in singular form for clarity. However, it should be noted that some embodiments include multiple iterations of a technique or multiple mechanisms unless noted otherwise. Similarly, various steps of the methods shown and described herein are not necessarily performed in the order indicated, or performed at all in certain embodiments. Accordingly, some implementations of the methods discussed herein may include more or fewer steps than those shown or described. Further, the techniques and mechanisms of the present invention will sometimes describe a connection, relationship or communication between two or more entities. It should be noted that a connection or relationship between entities does not necessarily mean a direct, unimpeded connection, as a variety of other entities or processes may reside or occur between any two entities. Consequently, an indicated connection does not necessarily mean a direct, unimpeded connection unless otherwise noted.
The following list of example features corresponds with the attached figures and is provided for ease of reference, where like reference numerals designate corresponding features throughout the specification and figures:
The mask 10 has two different configurations: a sealed configuration 11 (see
The scent agent may include a binding agent or an antimicrobial that is selected from a group consisting of: carboxymethyl cellulose, pullulan, hydroxypropyl methyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, polyvinyl pyrrolidone, polyvinyl alcohol, sodium alginate, polyethylene glycol, Xanthan gum, tragacanth gum, guar gum, acacia gum, arabic gum, polyacrylic acid, methyl methacrylate copolymer, carboxyvinyl polymer, amylose, high amylose starch, hydroxypropylated high amylose starch, dextrine, pectin, chitin, chitosan, levan, elsinan, collagen, gelatin, Zein, gluten, soy protein isolate, whey protein isolate, casein, and combinations thereof.
The impregnated layer 55 may be constructed from plastic films with pores or micro-holes, paper, sponge-like films, films with encapsulated scent agents, treated plastic films, and combinations thereof.
Although exemplary embodiments and applications of the invention have been described herein including as described above and shown in the included example Figures, there is no intention that the invention be limited to these exemplary embodiments and applications or to the manner in which the exemplary embodiments and applications operate or are described herein. Indeed, many variations and modifications to the exemplary embodiments are possible, as would be apparent to a person of ordinary skill in the art. The invention may include any device, structure, method, or functionality, as long as the resulting device, system or method falls within the scope of one of the claims that are allowed by the patent office based on this or any related patent application.
| Number | Name | Date | Kind |
|---|---|---|---|
| 4503851 | Braunroth | Mar 1985 | A |
| 5538013 | Brannon | Jul 1996 | A |
| 5891508 | Barnum | Apr 1999 | A |
| 6758215 | Begum | Jul 2004 | B2 |
| 6779524 | Strawder | Aug 2004 | B2 |
| 20050081856 | Cheng | Apr 2005 | A1 |
| 20060107959 | Plummer, Jr. | May 2006 | A1 |
| 20120090616 | Means | Apr 2012 | A1 |
| 20120144556 | Fiebel | Jun 2012 | A1 |
| 20140237695 | Al Malki | Aug 2014 | A1 |
| 20170021205 | Delatorre | Jan 2017 | A1 |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 16435476 | Jun 2019 | US |
| Child | 16511108 | US |
